Lipid metabolism is a significant section of energy homeostasis, and it affects the development of various
cancers. Previous studies have revealed that
berberine has strong anticancer and blood
lipid-lowering effects. Here, we further investigated the effects of
berberine on cell proliferation and lipogenesis in
colon cancer cells and the relationship between the two effects. We found that
berberine inhibited cell proliferation by inducing G0/G1 phase cell cycle arrest in
colon cancer cells. Moreover, the expressions of key lipogenic
enzymes were down-regulated by
berberine and led to the suppressed
lipid synthesis, which was linked to cell proliferation via Wnt/β-
catenin pathway. Importantly,
berberine inhibited
sterol regulatory
element-binding protein-1 (SREBP-1) activation and
SREBP cleavage-activating protein (SCAP) expression, resulting in the downregulation of these lipogenic
enzymes. Knockdown of SCAP by
shRNA could abolish the effect of
berberine on SREBP-1 activation. Besides the inhibitory effects in vitro,
berberine suppressed the growth and lipogenesis of
colon cancer xenograft in a SCAP-dependent manner as well. Together, our results suggest that
berberine may serve as a candidate against
tumor growth of
colon cancer partially through targeting SCAP/SREBP-1 pathway driving lipogenesis.